The 2026 Nobel Prize in Physiology or Medicine has been awarded to three researchers whose work unlocked a revolutionary method for controlling the activity of individual nerve cells using light, the Nobel Assembly announced Monday at the Karolinska Institutet in Stockholm.
Karl Deisseroth, 54, Peter Hegemann, 71, and Georg Nagel, 73, were recognized for their discoveries concerning light-gated ion channels and the field they helped create, known as optogenetics. The three scientists conduct their research at universities in Germany and the United States.
The announcement marks a significant moment for neuroscience, a discipline that has long sought precise tools to observe and manipulate the brain's complex circuitry. The prize committee honored the laureates for deciphering the mechanisms the brain uses to switch on or off the activity of individual nerve cells — a capability that has transformed how scientists study everything from memory formation to psychiatric disorders.
Optogenetics, the technique at the heart of the award, allows researchers to control neurons with unprecedented precision by using light to activate or silence specific cells. The approach relies on light-sensitive proteins — known as light-gated ion channels — that can be introduced into nerve cells, enabling scientists to trigger or suppress electrical signals simply by shining light on them.
Deisseroth is a professor in the Departments of Bioengineering and Psychiatry at Stanford University in California. He has been widely credited with advancing optogenetics into a practical laboratory tool and has received numerous international honors for his contributions, including the Japan Prize in the life sciences category, which he accepted at a ceremony in Tokyo in April 2023.
Hegemann and Nagel, both based in Germany, provided essential foundational discoveries that made the technology possible. Their investigations into how certain microorganisms respond to light revealed the existence and function of channelrhodopsins, the light-sensitive proteins that later became the molecular workhorses of optogenetics.
The Nobel Assembly's decision highlights the collaborative and international nature of modern scientific breakthroughs. The laureates' combined efforts bridged disciplines including biophysics, genetics, and neuroscience, yielding a method that researchers around the world now apply to study brain function in health and disease.
The award was announced during a press conference at the Nobel Forum at the Karolinska Institutet, where images of the three laureates were displayed on a screen. The Nobel committee praised their work as a transformative contribution to understanding how the nervous system operates at the cellular level.
Optogenetics has had far-reaching implications beyond basic research. Scientists have used the technique to map neural circuits involved in learning, reward, fear, and movement, and to investigate the roots of conditions such as Parkinson's disease, depression, and addiction. The ability to control specific neurons with light has also opened new avenues for potential therapies that target malfunctioning brain circuits.
The recognition comes as neuroscience continues to benefit from rapid technological innovation. Tools like optogenetics have allowed researchers to move from merely observing brain activity to actively manipulating it, a shift that has deepened understanding of how thoughts, emotions, and behaviors arise from the coordinated firing of nerve cells.
The prize, one of the most prestigious in the scientific world, is awarded annually by the Nobel Assembly at the Karolinska Institutet. It carries a monetary award and international recognition that often elevates the recipients to the forefront of public attention and scientific influence.
The three laureates join a distinguished lineage of researchers honored for discoveries in physiology or medicine. Their selection underscores the growing importance of neurotechnology and the tools that enable scientists to probe the brain's inner workings with increasing accuracy.
Deisseroth, Hegemann, and Nagel will be celebrated in the coming months at the traditional Nobel ceremonies. Their work stands as a testament to the power of curiosity-driven research, which often yields applications far beyond what the original investigators could have envisioned.
For patients and families affected by neurological and psychiatric conditions, the award also represents hope. While optogenetics is not yet a routine clinical treatment, the knowledge it has generated is guiding efforts to develop new interventions for disorders that have long resisted effective therapies.
The Nobel committee's announcement places the three scientists among the most influential figures in contemporary biology. Their discoveries have given the world a powerful lens — and a switch — for examining the brain, and have permanently changed the way scientists approach the study of the nervous system.
(0)